HOSPITAL UNIVERSITARIO RUBER
Fachbereich
Centre Eugène Marquis
Rennes, FranciaPublikationen in Zusammenarbeit mit Forschern von Centre Eugène Marquis (6)
2022
-
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial
JAMA Oncology, Vol. 8, Núm. 7, pp. 1047-1052
2021
-
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Annals of Oncology, Vol. 32, Núm. 9, pp. 1148-1156
-
Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial
Annals of Oncology, Vol. 32, Núm. 2, pp. 197-207
2020
-
ASCO 2020
Breast Care
-
Efficacy and Safety of Trastuzumab Emtansine plus Capecitabine vs Trastuzumab Emtansine Alone in Patients with Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Phase 1 and Randomized Phase 2 Trial
JAMA Oncology, Vol. 6, Núm. 8, pp. 1203-1209
-
Trastuzumab deruxtecan in previously treated HER2-positive breast cancer
New England Journal of Medicine, Vol. 382, Núm. 7, pp. 610-621